Our study illustrates the novel finding that PFKFB4 promotes angiogenesis in breast cancer via IL-6 instead of vascular endothelial growth factor (VEGF) which is a well-established mediator of angiogenesis in cancer. This evidence concerns the gene VEGFA and cancer.